title: A high titre of autoantibody at onset does not predict pancreatic beta-cell fate.
authors: Department of Internal Medicine, National Center for Global Health and Medicine Kohnodai Hospital, Chiba, Japan. Electronic address: dyanai@hospk.ncgm.go.jp.
authors: H
authors: H
authors: Yanai
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001786:Blood Glucose / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D005968:Glutamate Decarboxylase / Q000276:immunology; D006801:Humans; D000069036:Insulin Glargine / Q000627:therapeutic use; D050417:Insulin-Secreting Cells / Q000276:immunology / Q000378:metabolism; D008297:Male; D054635:Receptor-Like Protein Tyrosine Phosphatases, Class 8 / Q000276:immunology
chemical_list: D001323:Autoantibodies; D001786:Blood Glucose; D000069036:Insulin Glargine; D054635:Receptor-Like Protein Tyrosine Phosphatases, Class 8; D005968:Glutamate Decarboxylase
keywords: Beta-cell function; Glutamic acid decarboxylase autoantibody; IA2 autoantibody; Type 1 diabetes